Early phase II trial of oral vorinostat in relapsed or refractory breast, colorectal, or non-small cell lung cancer - Concepedia

Concepedia

Publication | Closed Access

Early phase II trial of oral vorinostat in relapsed or refractory breast, colorectal, or non-small cell lung cancer

172

Citations

17

References

2008

Year

Johan Vansteenkiste, Eric Van Cutsem, Herlinde Dumez, Cong Chen, Justin L. Ricker, Sophia Randolph, Patrick Schöffski

Investigational New Drugs

MedicineRefractory BreastBronchial NeoplasmBreast CancerCancer TreatmentOncologyRadiation OncologyOral VorinostatLung Cancer

References

	Year	Citations

Page 1